On April 6, analysts at Wedbush led by Liana Moussatos highlighted upcoming events in the biotech sector. Here is what to watch for: OvaScience Inc …
A handful of bio-pharmaceutical stocks are announcing their financial results for the final quarter of 2014 this week. What should investors watch for?
In a research report published today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Tetraphase Pharmaceuticals (NASDAQ:TTPH) with a $50 price …
In a research report sent to investors today this morning, Cantor analyst Daniel Brims reiterated a Buy rating on Tetraphase Pharmaceuticals (NASDAQ:TTPH) and raised …
Tetraphase pharmaceuticals (NASDAQ: TTPH) shares rose 17.5% in after-hours trading on December 17th after the company announced its antibiotic to treat complicated intra-abdominal infections proved …
Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Tetraphase Pharmaceuticals (NASDAQ:TTPH) with a $23 price target, which (surprisingly) represents a slight …
In a research report issued today, Brean Capital analyst Jonathan Aschoff maintained a Buy rating on Tetraphase Pharmaceuticals (NASDAQ:TTPH) with a $23.00 price …
